1,366
Views
8
CrossRef citations to date
0
Altmetric
Systematic Review and Meta-analysis

Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis

ORCID Icon, &
Pages 853-866 | Received 12 Dec 2021, Accepted 25 Feb 2022, Published online: 09 Mar 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jeffrey M Witkin, Lalit K Golani & Jodi L Smith. (2023) Clinical pharmacological innovation in the treatment of depression. Expert Review of Clinical Pharmacology 16:4, pages 349-362.
Read now
Andrzej Pilc, Agata Machaczka, Paweł Kawalec, Jodi L. Smith & Jeffrey M. Witkin. (2022) Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism. Expert Opinion on Drug Discovery 17:10, pages 1131-1146.
Read now

Articles from other publishers (5)

Giacomo d'Andrea, Mauro Pettorruso, Giorgio Di Lorenzo, Gianluca Mancusi, Roger S. McIntyre & Giovanni Martinotti. (2023) Rethinking ketamine and esketamine action: Are they antidepressants with mood-stabilizing properties?. European Neuropsychopharmacology 70, pages 49-55.
Crossref
Antonio Tundo, Sophia Betro’, Rocco de Filippis, Fulvia Marchetti, Daniele Nacca, Roberta Necci & Marica Iommi. (2023) Pramipexole Augmentation for Treatment-Resistant Unipolar and Bipolar Depression in the Real World: A Systematic Review and Meta-Analysis. Life 13:4, pages 1043.
Crossref
Yu-Jung Cheng, Chieh-Hsin Lin & Hsien-Yuan Lane. (2023) Ketamine, benzoate, and sarcosine for treating depression. Neuropharmacology 223, pages 109351.
Crossref
Christoph U. Correll, Marco Solmi, Samuele Cortese, Maurizio Fava, Mikkel Højlund, Helena C. Kraemer, Roger S. McIntyre, Daniel S. Pine, Lon S. Schneider & John M. Kane. (2023) The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de‐risk trial programmes of novel agents. World Psychiatry 22:1, pages 48-74.
Crossref
Haihua Tian, Zhenyu Hu, Jia Xu & Chuang Wang. (2022) The molecular pathophysiology of depression and the new therapeutics. MedComm 3:3.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.